These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18685388)

  • 1. Opioid-induced immunosuppression.
    Sacerdote P
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):14-8. PubMed ID: 18685388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the immune system.
    Sacerdote P
    Palliat Med; 2006; 20 Suppl 1():s9-15. PubMed ID: 16764216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opioids and immunosuppression. Clinical relevance?].
    Welters I
    Anaesthesist; 2003 May; 52(5):442-52. PubMed ID: 12750829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment.
    Franchi S; Panerai AE; Sacerdote P
    Brain Behav Immun; 2007 Aug; 21(6):767-74. PubMed ID: 17291715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression.
    Sacerdote P; Franchi S; Panerai AE
    Curr Pharm Des; 2012; 18(37):6034-42. PubMed ID: 22747543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain management: is opioid immunosuppression a clinical problem?
    Budd K
    Biomed Pharmacother; 2006 Aug; 60(7):310-7. PubMed ID: 16860971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthesia drugs, immunity, and long-term outcome.
    Homburger JA; Meiler SE
    Curr Opin Anaesthesiol; 2006 Aug; 19(4):423-8. PubMed ID: 16829725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
    Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
    Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.
    Kress HG
    Eur J Pain; 2009 Mar; 13(3):219-30. PubMed ID: 18567516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
    Hass B; Lungershausen J; Hertel N; Poulsen Nautrup B; Kotowa W; Liedgens H
    Eur J Health Econ; 2009 Jul; 10(3):309-21. PubMed ID: 19101743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect on morphine and other opioids on immune function].
    Ernst G; Pfaffenzeller P
    Schmerz; 1998 Jul; 12(3):187-94. PubMed ID: 12799971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003).
    Ryle PR
    Fundam Clin Pharmacol; 2005 Jun; 19(3):317-22; discussion 329-30. PubMed ID: 15910654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effect of morphine: therapeutic implications.
    Dinda A; Gitman M; Singhal PC
    Expert Opin Drug Saf; 2005 Jul; 4(4):669-75. PubMed ID: 16011446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of opioids on phagocytic function, oxidative burst capacity, cytokine production and apoptosis in canine leukocytes.
    Declue AE; Yu DH; Prochnow S; Axiak-Bechtel S; Amorim J; Tsuruta K; Donaldson R; Lino G; Monibi F; Honaker A; Dodam J
    Vet J; 2014 May; 200(2):270-5. PubMed ID: 24679456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram enhances B cell numbers in a murine model of morphine-induced immunosuppression.
    Nguyen T; Kramer J; Vallejo R; Stanton G; Heidenreich BA; Benyamin R; Vogel LA
    Pain Pract; 2009; 9(3):195-205. PubMed ID: 19226315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opioids and their immunomodulatory properties].
    Blahoutová V; Zajícová A; Wilczek H; Holán V
    Cas Lek Cesk; 2003; 142(4):244-7. PubMed ID: 12841129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.